Data-Driven Insights

June 3, 2014   |   Ally Hanlon

Dr. Adam Fein to Keynote IntegriChain’s 6th Annual Innovation Summit

Adam J. Fein, Ph.D. to Keynote at Innovation Summit

The IntegriChain team is very excited to announce that Adam J. Fein, Ph.D., will be the keynote at this year's IntegriChain Innovation Summit, being held September 8th - September 10th at the Omni William Penn Hotel in Pittsburgh, PA!

As the keynote speaker, Dr. Fein will be the cherry on top of our content-rich agenda. Dr. Fein is the President of Pembroke Consulting and CEO of Drug Channels Institute and is one of the country's foremost experts on pharmaceutical economics and the drug distribution system. Top manufacturers call on Dr. Fein's insights and judgement to create successful commercial strategies and make better strategic decisions in the evolving healthcare environment. Dr. Fein excels at unlocking and explaining complex business and economics issues with humor and an accessible, straightforward style, and has thus become a popular and authoritative figure in the industry.

Read More

Tags:


April 29, 2014   |   Jason Bogroff

Guest Blog Post: Jason Bogroff of Blue Fin Group on Specialty Data

Jason Bogroff Blue Fin Group

The IntegriChain team will be attending the Armada Specialty Pharmacy Summit & Expo next week in Las Vegas, NV. With specialty pharmacy at the forefront of our minds, we have asked Jason Bogroff, Principal Consultant at Blue Fin Group, to share with us his insights into specialty pharmacy, including emerging pharmacy models and implications of specialty data.

Jason is a sought after expert in translating technical complexity and ambiguity into innovative tactics and executable plans. He is recognized for his creative excellence in applying his combination of business and technical acumen to client needs that span the breadth of Healthcare commerce. Blue Fin Group clients have mined significant value as Jason applies his outstanding project management skills and deep methodology understanding across the areas of channel and customer operations, forecasting, planning and replenishment, channel data and analytics, enterprise technology, logistics and engineering, product and service design and development, and business process design and optimization.

Read More

Tags:


April 22, 2014   |   Ally Hanlon

A Product Manager’s Thoughts on Customer Experience & Relationships

"2014 is the Year of Empathy" Article by: Bruce Temkin

I was reading Supply & Demand Chain Executive today and came across an article from Bruce Temkin entitled, "2014 is the Year of Empathy." The article caught my eye because I was just talking with a colleague the other day discussing an article stating that compassion was one of the biggest tools that an organization can use to increase employee satisfaction. As a Product Manager, there is nothing more important in my job than understanding how other people think, act, and feel. To my delight, I opened up the article and found that it was all about customer experience.

Read More

Tags: ,


April 15, 2014   |   Ally Hanlon

Join us on May 14th for Our Free Webinar: Benchmark Findings for Pharmaceutical Channel, Inventory & Service Level Trends

Check Out Our 2014 Benchmark Study

Every year, IntegriChain releases benchmark data on pharmaceutical channel, inventory and service level trends. This April, IntegriChain will be releasing our latest version of the Benchmark Study on Pharmacy Stocking & Inventory Trends in Wholesale & Retail, with data going through Q4 2013. To officially unveil the results of this study, our team of subject matter experts will be hosting a FREE webinar: Benchmark Findings for Pharmaceutical Channel, Inventory & Service Level Trends on Wednesday, May 14th from 1pm to 2pm EST.

Read More

Tags:


April 8, 2014   |   Ally Hanlon

Empty Shelves – Amazon’s Best Friend

Brick & Mortar vs. Online Retailers

The other day on my lunch break I popped into a national cosmetic retailer well known and much loved by many women for its seemingly endless rows of shelves displaying little tubes and vials of potions that promise youth and attractiveness. For many shoppers this beauty oasis elicits full sensory overload ultimately culminating in more than one impulse purchase. Despite the fact that at first glance the shelves usually appear full of products, I have more than once walked away empty-handed due to that item being out of stock, and this particular trip was no exception. Sure enough, after the beauty consultant made her pitch and recommended a high-end eye primer (by the label Dior no less), imagine her embarrassment and my disappointment when we discovered that the product was actually out of stock. She checked multiple hidden drawers hunting for a stray potted primer - all without luck. And so I was faced with a choice. I could get an alternative product, or I could go online and order it on Amazon for less moeny and with free shipping (thank you, Amazon Prime!).

Read More

Tags:


April 1, 2014   |   Josh Halpern

Can Pharma Do VMI or CPFR

CPFR & VMI in Life Sciences?

Over the past fifteen years, concepts like Vendor Managed Inventory (VMI) and Collaborative Planning, Forecasting and Replenishment (CPFR) have become commonplace in many verticals. But propose VMI or CPFR at a Life Sciences channel management brainstorming session and you will get some interesting looks. The order management/supply chain folks in the room chuckle. Trade shakes its head from side to side, as if to say, "Not in my lifetime..." Pretty much everyone else wonders what VMI and CPFR mean. So I'll ask the provocative question - why not VMI and/or CPFR in Life Sciences? Life Science companies sell through demand networks, just like the many consumer product companies who have made VMI and CPFR well-honed business processes. In this post, I'd like to examine what I think the reason is - and ask whether the logic still applies.

Read More

Tags: , , , ,


April 1, 2014   |   Ally Hanlon

Did You Miss Our Webcast on Outside in Order Management with Supply Chain Insights?

Order Management Webcast Now Available On-Demand

Did you miss our co-hosted webcast on March 20th entitled, "Outside In Order Management," with Lora Cecere, Founder & CEO of Supply Chain Insights? No worries! It is now available on-demand. In the webcast, Lora took us on a deep dive into the new "outside in" methodology of using actual channel data to make informed order decisions. Lora covered all the bases and went into depth on how this new methodology ultimately helps to advance inventory turns and improves operating margins, as well as how suppliers can use advanced analytics to sense order flows and yield exceptions to drive a better supply chain response.

Read More

Tags: ,


March 27, 2014   |   Ally Hanlon

Registration is Now Open for The 2014 DNA Innovation Summit

Register today for the 2014 DNA Innovation Summit!

We are excited to announce that registration is now officially open for the 2014 DNA Innovation Summit! This year's event is being held Monday, September 8 through Wednesday, September 10 at the Omni William Penn Hotel in Pittsburgh, PA. This year's event will be the biggest and best yet! Not only will we be focusing on Demand Network Analytics (DNA), our suite of cloud-based informed applications, but we will also feature several sessions by industry experts on channel data trends within the pharmaceutical industry.

Read More

Tags:


March 25, 2014   |   Josh Halpern

What Happens When Doctors Start Asking Who Makes Your Generic?

Who makes your generic?

I recently read an article by Toni Clarke and Bill Berkrot, "Unease grows among US doctors over Indian drug quality." The piece raised some interesting points around the quality of imported drugs and the fact that doctors are starting to question the origin of the drugs they are prescribing to their patients. Recently, the FDA banned the importation of products from certain pharmaceutical manufacturers due to quality control problems, including data manipulation and sanitation. According to the article, "Some US doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration."

Read More

Tags: , , ,


March 18, 2014   |   Kevin Leininger

Informed Applications: The Next Generation Beyond Analytics – Part Two

Kevin E. Leinger IntegriChain CEO

Kevin Leininger is CEO at IntegriChain. He has spent the last 20 years building and launching software and services companies in the financial services, petroleum, and pharmaceutical industries, and he is extremely passionate about the ways that data can transform business processes through the power of technology. What Are Informed Applications The pace of business is accelerating and companies are struggling to keep up with the need for more rapid decision-making and action taking to support it. The problem with legacy applications and analytics is that they are not built to support the vast majority of decisions that need to be made by an organization on a daily or weekly basis.

Read More

Tags:


adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand